Effects of five preoperative cardiovascular drugs on mortality after coronary artery bypab surgery

European Journal of Anaesthesiology

Volumn 33, Issue 1, 2016, Pages 49-57

  Venkatesan, Sudhir ^a   Okoli, George N ^a   Mozid, Abdul M ^b   Pickworth, Thomas W H ^c   Grocott, Michael P W ^d   Sanders, Robert D ^e   Myles, Puja ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CERIVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; CARDIOVASCULAR AGENT;

AGED; ARTICLE; CORONARY ARTERY BYPASS SURGERY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; PREOPERATIVE TREATMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL MORTALITY; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; LIFESTYLE; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PREOPERATIVE CARE; PROCEDURES; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIFE STYLE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES;

EID: 84957590822     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000340     Document Type: Article

References (34)

1. Minino AM, Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2008. Natl Vital Stat Rep 2011; 59:1-126.
2. Townsend NWK, Bhatnagar P, Smolina K, et al. Coronary disease statistics 2012 edition. London: British Heart Foundation; 2012.
3. Campeau L. Lipid lowering and coronary bypab graft surgery. Curr Opin Cardiol 2000; 15:395-399.
4. Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Abociation Task Force on Practice Guidelines, and the American Abociation for Thoracic Surgery, Preventive Cardiovascular Nurses Abociation, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2014; 130:1749-1767.
5. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA guidelines for coronary artery bypab graft surgery: executive summary and recommendations: a report of the American College of Cardiology/American Heart Abociation Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypab graft surgery). Circulation 1999; 100:1464-1480.
6. Saxena A, Kapoor J, Dinh DT, et al. Preoperative atrial fibrillation is an independent predictor of worse early and late outcomes after isolated coronary artery bypab graft surgery. J Cardiol 2015; 65:224-229.
7. Bottle A, Mozid A, Grocott HP, et al. Preoperative stroke and outcomes after coronary artery bypab graft surgery. Anesthesiology 2013; 118:885-893.
8. Priebe HJ. Triggers of perioperative myocardial ischaemia and infarction. Br J Anaesth 2004; 93:9-20.
9. Liakopoulos OJ, Kuhn EW, Slottosch I, et al. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev 2012; 4:CD008493.
10. Winchester DE, Wen X, Xie L, Bavry AA. Evidence of preprocedural statin therapy a meta-analysis of randomized trials. J Am Coll Cardiol 2010; 56:1099-1109.
11. Kuhn E, Liakopoulos O, Stange S, et al. Meta-Analysis of patients taking statins before revascularization and aortic valve surgery. Ann Thorac Surg 2013; 96:1508-1516.
12. Kuhn E, Liakopoulos O, Stange S, et al. Preoperative statin therapy in cardiac surgery: a meta-analysis of 90 000 patients. Eur J Cardiothorac Surg 2014; 45:17-26.
13. Papathanasiou A, Toumpoulis IK, Milionis HJ, et al. Statin therapy is abociated with reduced total and cardiovascular mortality after coronary artery bypab grafting surgery. Coron Artery Dis 2008; 19:619-625.
14. Kulik A, Brookhart MA, Levin R, et al. Impact of statin use on outcomes after coronary artery bypab graft surgery. Circulation 2008; 118:1785-1792.
15. Huffmyer JL, Mauermann WJ, Thiele RH, et al. Preoperative statin administration is abociated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypab graft surgery. J Cardiothorac Vasc Anesth 2009; 23:468-473.
16. Ferguson TB Jr, Coombs LP, Peterson ED. Society of Thoracic Surgeons National Adult Cardiac Surgery D. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002; 287:2221-2227.
17. Lin T, Hasaniya NW, Krider S, et al. Mortality reduction with beta-blockers in ischemic cardiomyopathy patients undergoing coronary artery bypab grafting. Congest Heart Fail 2010; 16:170-174.
18. O'Neal W, Efird JT, Davies SW, et al. Discharge b-blocker use and race after coronary artery bypab grafting. Front Public Health 2014; 2:94.
19. Brinkman W, Herbert MA, O'Brien S, et al. Preoperative b-blocker use in coronary artery bypab grafting surgery: National Database Analysis. JAMA Intern Med 2014; 174:1320-1327.
20. Wiesbauer F, Schlager O, Domanovits H, et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesth Analg 2007; 104:27-41.
21. Ji F, Li Z, Nguyen H, et al. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation 2013; 127:1576-1584.
22. Yacoub R, Patel N, Lohr JW, et al. Acute kidney injury and death abociated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studies. Am J Kidney Dis 2013; 62:1077-1086.
23. Bandeali S, Kayani W, Lee V, et al. Outcomes of preoperative angiotensinconverting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypab grafting. Am J Cardiol 2012; 110:919-923.
24. Wijeysundera D, Beattie W, Rao V, et al. Calcium antagonists are abociated with reduced mortality after cardiac surgery: a propensity analysis. J Thorac Cardiovasc Surg 2004; 127:755-762.
25. Wijeysundera DN, Beattie WS, Rao V, Karski J. Calcium antagonists reduce cardiovascular complications after cardiac surgery: a meta-analysis. J Am Coll Cardiol 2003; 41:1496-1505.
26. Herrett E, Shah A, Boggon R, et al. Completeneb and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ (Online) 2013; 346:f2350.
27. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of clabifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383.
28. Bouchard D, Carrier M, Demers P, et al. Statin in combination with betablocker therapy reduces postoperative stroke after coronary artery bypab graft surgery. Ann Thorac Surg 2011; 91:654-659.
29. Shahian DM, O'Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypab grafting surgery. Ann Thorac Surg 2009; 88:S2-S22.
30. Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg 2012; 41:734-744.
31. Bottle A, Mozid A, Grocott HP, et al. Preoperative risk factors in 10 418 patients with prior myocardial infarction and 5241 patients with prior unstable angina undergoing elective coronary artery bypab graft surgery. Br J Anaesth 2013; 111:417-423.
32. Anderson R. First publications from the Society of Thoracic Surgeons National Database. Ann Thorac Surg 1994; 57:6-7.
33. Nashef S, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16:9-13.
34. Manning H, Martin J, Jameson SS, Sanders RD. Predicting perioperative risk and informed consent. Ann Surg 2015; 261:e40.